Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Experimental adhesion prophylaxis with recombinant tissue plasminogen activator

M N Vipond1, S A Whawell, D M Scott-Coombes

  • 1Academic Surgical Unit, St Mary's Hospital, London.

Annals of the Royal College of Surgeons of England
|November 1, 1994
PubMed
Summary

Recombinant tissue plasminogen activator (rtPA) significantly reduced peritoneal adhesions in rats. This localized treatment shows promise for preventing post-surgical adhesions in clinical settings.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A 15-year experience: intraoperative parathyroid hormone assay for the management of primary hyperparathyroidism in a UK endocrine surgical unit.

Langenbeck's archives of surgery·2023
Same author

Evolution and parathyroid surgery.

The British journal of surgery·2021
Same author

Outcomes of surgery for benign and malignant adrenal disease from the British Association of Endocrine and Thyroid Surgeons' national registry.

The British journal of surgery·2019
Same author

Intraoperative Parathyroid Hormone Assay Remains Predictive of Cure in Renal Impairment in Patients with Single Parathyroid Adenomas.

World journal of surgery·2018
Same author

Is Unilateral Neck Surgery Feasible in Patients with Sporadic Primary Hyperparathyroidism and Double Negative Localisation?

World journal of surgery·2017
Same author

A decade of change in the uptake of parathyroidectomy in England and Wales.

Annals of the Royal College of Surgeons of England·2014

Area of Science:

  • Surgical research
  • Biomedical engineering
  • Wound healing

Background:

  • Peritoneal adhesions, a consequence of fibrin deposition, can lead to complications.
  • Preventing adhesion formation is crucial in surgical recovery.

Purpose of the Study:

  • To investigate the efficacy of localized recombinant tissue plasminogen activator (rtPA) in preventing peritoneal adhesion formation.
  • To assess rtPA's potential as a therapeutic agent for adhesion prevention.

Main Methods:

  • A rat model with standardized peritoneal ischemic sites was utilized.
  • Animals received intraperitoneal treatments: no treatment, carboxymethylcellulose gel, or rtPA-carboxymethylcellulose gel.
  • Adhesion formation was quantified at one week post-treatment.

Related Experiment Videos

Main Results:

  • rtPA-treated rats exhibited significantly fewer adhesions compared to controls (median 1.5 vs. 2.5 vs. 5, P < 0.001).
  • A slow-release formulation of intraperitoneal rtPA demonstrated a marked reduction in adhesion formation.

Conclusions:

  • Intraperitoneal rtPA in a slow-release formulation effectively reduces adhesion formation in an animal model.
  • This approach holds potential for clinical application in preventing post-surgical adhesions.